Literature DB >> 17671716

Down-regulation of EDAG expression by retrovirus-mediated small interfering RNA inhibits the growth and IL-8 production of leukemia cells.

Bin Ling1, Ying Zhou, Dingqing Feng, Guodong Shen, Ting Gao, Yongyun Shi, Haiming Wei, Zhigang Tian.   

Abstract

Embryonic development associated gene (EDAG), which is overexpressed in hematopoietic neoplasms and leukemia cell lines, has been reported to participate in the leukemia cell differentiation and proliferation. This study investigated whether retrovirus-mediated transfer of a siRNA against EDAG can reduce the growth of leukemia cells which highly express EDAG in vitro and in vivo. The stable transfected cells were identified with RT-PCR, the effect of EDAG/siRNA on the growth of the human erythroleukemia cell line HEL was analyzed by MTT assay, and angiogenic factor IL-8 release was evaluated by ELISA and RT-PCR. The results showed that EDAG/siRNA can silence the expression of EDAG in HEL cells. Down-regulation of EDAG expression by retrovirus-mediated siRNA inhibited the cell proliferation and tumor growth. Knockdown of EDAG expression by siRNA is also associated with decreased expression of the anti-angiogenic factor IL-8, suggesting that EDAG stimulates tumor growth at least in part by regulating angiogenesis. This study suggests that siRNA-mediated gene silencing of EDAG could potentially be a therapeutic strategy for EDAG over-expressing leukemia cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671716

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  2 in total

1.  EDAG-1 promotes proliferation and invasion of human thyroid cancer cells by activating MAPK/Erk and AKT signal pathways.

Authors:  Dan-Lei Chen; Zhong-Qian Hu; Xian-Fang Zheng; Xin-Yi Wang; You-Zhi Xu; Wen-Qing Li; Hao-Shu Fang; Lixin Kan; Si-Ying Wang
Journal:  Cancer Biol Ther       Date:  2016-03-02       Impact factor: 4.742

2.  Adsorption and release of siRNA from porous silica.

Authors:  Jeremy L Steinbacher; Christopher C Landry
Journal:  Langmuir       Date:  2013-10-23       Impact factor: 3.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.